119 related articles for article (PubMed ID: 29026401)
1. The sensitivity of Na
Omar AK; Ahmed KA; Helmi NM; Abdullah KT; Qarii MH; Hasan HE; Ashwag A; Nabil AM; Abdu AM; Salama MS
Afr Health Sci; 2017 Mar; 17(1):262-269. PubMed ID: 29026401
[TBL] [Abstract][Full Text] [Related]
2. Altered Na(+)-K+ ATPase activity in uraemic adolescents.
Vásárhelyi B; Sallay P; Balog E; Reusz G; Tulassay T
Acta Paediatr; 1996 Aug; 85(8):919-22. PubMed ID: 8863871
[TBL] [Abstract][Full Text] [Related]
3. Effect of age on red cell membrane sodium -potassium dependent adenosine triphosphatase (Na+-K+ ATPase) activity in healthy men.
Gambert SR; Duthie EH
J Gerontol; 1983 Jan; 38(1):23-5. PubMed ID: 6294172
[TBL] [Abstract][Full Text] [Related]
4. Reduced Na(+), K(+)-ATPase activity in erythrocyte membranes from patients with phenylketonuria.
Bedin M; Estrella CH; Ponzi D; Duarte DV; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
Pediatr Res; 2001 Jul; 50(1):56-60. PubMed ID: 11420419
[TBL] [Abstract][Full Text] [Related]
5. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
Maslova MN; Ogorodnikova LE; Titkov IuS
Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
Raccah D; Gallice P; Pouget J; Vague P
Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of membrane Na(+)-K+ Atpase of the brain, liver and RBC in rats administered di(2-ethyl hexyl) phthalate (DEHP) a plasticizer used in polyvinyl chloride (PVC) blood storage bags.
Dhanya CR; Indu AR; Deepadevi KV; Kurup PA
Indian J Exp Biol; 2003 Aug; 41(8):814-20. PubMed ID: 15248477
[TBL] [Abstract][Full Text] [Related]
8. [Na K ATPase changes in the erythrocyte membrane in subjects treated with inosine].
L'Abbate N; Montemurro G; Lappa B
Arch Sci Med (Torino); 1978; 135(4):585-8. PubMed ID: 228634
[TBL] [Abstract][Full Text] [Related]
9. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney.
Raccah D; Lamotte-Jannot MF; Issautier T; Vague P
Diabete Metab; 1994; 20(3):271-4. PubMed ID: 8001715
[TBL] [Abstract][Full Text] [Related]
10. Abnormal erythrocyte Na, K-ATPase activity in a northeastern Thai population.
Tosukhowong P; Chotikasatit C; Tungsanga K; Sriboonlue P; Prasongwattana V; Pansin P; Sitprija V
Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):526-30. PubMed ID: 1336901
[TBL] [Abstract][Full Text] [Related]
11. Properties of a membrane-bound phosphatase activity in normal and abnormal red blood cells.
Delaunay J; Fischer S; Piau JP; Tortolero M; Schapira G
Clin Chim Acta; 1979 Apr; 93(1):15-24. PubMed ID: 219973
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid, transketolase and Na+, K+, ATPase in patients with rheumatoid arthritis.
Kiziltunç A; Coğalgil S; Uğur M; Avci B; Akçay F
Clin Chem Lab Med; 1998 May; 36(5):289-93. PubMed ID: 9676385
[TBL] [Abstract][Full Text] [Related]
13. Variables affecting measurement of human red cell Na+,K+ATPase activity: technical factors, feeding, aging.
Simat BM; Morley JE; From AH; Briggs JE; Kaiser FE; Levine AS; Ahmed K
Am J Clin Nutr; 1984 Aug; 40(2):339-45. PubMed ID: 6147085
[TBL] [Abstract][Full Text] [Related]
14. Effects of Iron Overload on the Activity of Na,K-ATPase and Lipid Profile of the Human Erythrocyte Membrane.
Sousa L; Garcia IJ; Costa TG; Silva LN; Renó CO; Oliveira ES; Tilelli CQ; Santos LL; Cortes VF; Santos HL; Barbosa LA
PLoS One; 2015; 10(7):e0132852. PubMed ID: 26197432
[TBL] [Abstract][Full Text] [Related]
15. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
[TBL] [Abstract][Full Text] [Related]
16. Effect of hemolysate on calcium inhibition of the (Na+ + K+)-ATPase of human red blood cells.
Yingst DR; Marcovitz MJ
Biochem Biophys Res Commun; 1983 Mar; 111(3):970-9. PubMed ID: 6301494
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte sodium/potassium adenosine triphosphatase in thyroid disease and nonthyroidal illness.
Dasmahapatra A; Cohen MP; Grossman SD; Lasker N
J Clin Endocrinol Metab; 1985 Jul; 61(1):110-5. PubMed ID: 2987290
[TBL] [Abstract][Full Text] [Related]
18. [Na K ATPase activity in mammalian erythrocytes].
Kazennov AM; Maslova MN; Shalabodov AD
Biokhimiia; 1984 Jul; 49(7):1089-95. PubMed ID: 6089915
[TBL] [Abstract][Full Text] [Related]
19. [Changes in Na+, K+-ATPase and acetylcholinesterase activity in red cell membranes after freezing-thawing].
Lugovoĭ VI; Guseva NP
Ukr Biokhim Zh (1978); 1981; 53(3):55-8. PubMed ID: 6266109
[TBL] [Abstract][Full Text] [Related]
20. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
